Finance

Lists
002287:SHE
Tibet Cheezheng Tibetan Medicine Co Ltd
CNÂ¥20.34
+0.99%
(+0.20) 1D
Sep 1, 3:04:42 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002287...
Open
CNÂ¥20.14
High
CNÂ¥20.38
Low
CNÂ¥20.05
Mkt. cap
11.52B
Avg. vol.
2.56M
Volume
1.61M
Dividend
3.10%
Quarterly dividend
CNÂ¥0.16
Ex-dividend date
Jun 17, 2026
P/E ratio
17.37
52-wk high
CNÂ¥28.90
52-wk low
CNÂ¥18.33
EPS
CNÂ¥1.17
Shares outstanding
572.12M
No. of employees
3K
Open
CNÂ¥20.14
High
CNÂ¥20.38
Low
CNÂ¥20.05
Mkt. cap
11.52B
Avg. vol.
2.56M
Volume
1.61M
Dividend
3.10%
Quarterly dividend
CNÂ¥0.16
Ex-dividend date
Jun 17, 2026
P/E ratio
17.37
52-wk high
CNÂ¥28.90
52-wk low
CNÂ¥18.33
EPS
CNÂ¥1.17
Shares outstanding
572.12M
No. of employees
3K
Profile
Tibet Cheezheng Tibetan Medicine, or Tibet Qizheng Tibetan Medicine Co., Ltd is a prominent firm in the Tibetan medicine sector in China, primarily focused on the research, development, manufacture, and sales of Tibetan medicinal products. Wikipedia
About Tibet Cheezheng Tibetan Medicine Co Ltd
CEO-
Employees3.2K
Founded1995
Headquarters-
SectorPharmaceutical industry
Websitecheezheng.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
347.89M
893.07M
405.25M
572.72M
Cost of goods sold
61.48M
140.40M
65.12M
110.15M
Cost of revenue
61.48M
140.40M
65.12M
110.15M
Research and development expenses
17.52M
31.37M
14.95M
17.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
264.43M
467.36M
231.41M
178.35M
Operating expense
287.80M
506.73M
250.16M
161.56M
Total operating expenses
349.28M
647.13M
315.28M
271.72M
Operating income
-1.40M
245.94M
89.97M
301.00M
Other non operating income
269.69K
-863.06K
462.08K
-2.04M
EBT including unusual items
69.67M
267.60M
109.04M
305.43M
EBT excluding unusual items
-8.28M
245.93M
90.15M
299.24M
Income tax expense
5.56M
43.69M
15.07M
29.25M
Effective tax rate
7.98%
16.33%
13.82%
9.58%
Other operating expenses
4.85M
9.39M
3.92M
-34.88M
Net income
65.12M
224.91M
95.18M
276.12M
Net profit margin
18.72%
25.18%
23.49%
48.21%
Earnings per share
-
-
-
-
Interest and investment income
1.78M
3.52M
1.77M
2.05M
Interest expense
-9.89M
-2.55M
-2.05M
-1.77M
Net interest expenses
-8.11M
978.68K
-280.98K
280.98K
Depreciation and amortization charges
-
-
-
-
EBITDA
25.60M
279.82M
123.85M
336.04M
Gain or loss from assets sale
909.31K
-7.38M
-
-248.14K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps